Recruiting
Colorectal cancer
RecruitingStudy Comparing Amivantamab and Chemotherapy Versus Cetuximab and Chemotherapy for Patients with Advanced Colorectal Cancer
Registered drugNo placebo
Study Comparing Amivantamab and Chemotherapy Versus Cetuximab and Chemotherapy for Patients with Advanced Colorectal Cancer
Registered drugNo placebo
- Disease:Colorectal cancer
- Substances:AmivantamabCetuximab
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Amivantamab
- Sponsor:Janssen Cilag International





